Massachusetts · 194th Legislature (2025-2026) · Bill
H 2472: An Act protecting patient safety regarding non-FDA approved drugs
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2472 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act protecting patient safety regarding non-FDA approved drugs. Primary sponsor: Kathy LaNatra (Democratic). It lists 1 additional sponsor. Most recent recorded action (March 16, 2026): Accompanied a study order, see H5234.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative LaNatra of Kingston, a petition (accompanied by bill, House, No. 2472) of Kathleen R. LaNatra and Patrick Joseph Kearney relative to the distribution of compounded medications. Public Health.
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kathy LaNatra | Primary sponsor | Democratic | House | 12th Plymouth |
| Patrick Kearney | Co-sponsor | Democratic | House | 4th Plymouth |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Accompanied a study order, see H5234
- Reporting date extended to Thursday, October 9, 2025
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health